Moffitt Cancer Center 17th Annual Clinical Breakthroughs and Challenges in Hematologic Malignancies 2022
Format: 14 videos + 1 pdf, size: 1.83 GB
Course Audience: oncologist, hematologist
Course Syllabus (PDF Format)
AML MDS Debate Should MRD be Used to Guide Transplant Decisions In AML and MDS (Video TS Format)
AML MDS Interactive Case Discussion Using Molecular Monitoring to Guide Therapy in AML (Video TS Format)
AML MDS State of the Art Frontline Management of the Higher Risk MDS Patient (Video TS Format)
Hot Topics COVID-19 in Cancer Patients Outcomes and Prevention (Video TS Format)
Hot Topics Managing Hematologic Toxicity from Immunotherapeutic Agents (Video TS Format)
Hot Topics Pre-Leukemic Mutations in the Blood Reason to Worry (Video TS Format)
Hot Topics Updates on the role of CAR-T in Lymphoma (Video TS Format)
Lymphoid Malignancies Debate Should Next Generation Sequencing be Reported In All Newly Diagnosed Lymphomas (Video TS Format)
Lymphoid Malignancies Interactive Case Discussion Treatment of Relapsed Refractory Diffuse Large B-cell Lymphoma (Video TS Format)
Lymphoid Malignancies State of the Art Best Frontline therapy for CLL (Video TS Format)
Multiple Myeloma Debate How Much is Enough (or Too Much) in Newly Diagnosed Multiple Myeloma-Triplet Therapy vs Quadruplet therapy Ken Shain (Video TS Format)
Multiple Myeloma Debate How Much is Enough (or Too Much) in Newly Diagnosed Multiple Myeloma-Triplet Therapy vs Quadruplet therapy Rachid Baz (Video TS Format)
Multiple Myeloma Interactive Case Discussion Novel Immune Based Therapy for Relapsed Refractory Multiple Myeloma (Video TS Format)
Multiple Myeloma State of the Art BCMA CAR T-Therapy for Multiple Myeloma- Real World Experience (Video TS Format)